108 related articles for article (PubMed ID: 20923039)
1. Rare bladder tumors: caveat emptor.
Wilson SS; Theodorescu D
Oncology (Williston Park); 2010 Aug; 24(9):838. PubMed ID: 20923039
[No Abstract] [Full Text] [Related]
2. Solitary extramedullary plasmacytoma of the bladder: a case report and literature.
Khaliq W; Uzoaru I; Konchanin RP; Sapiente RA; Egner JR
Oncology (Williston Park); 2010 Aug; 24(9):832-5. PubMed ID: 20923037
[TBL] [Abstract][Full Text] [Related]
3. Unusual presentation of multiple myeloma.
Shenoy K; Boloor A; Pai S; Suddharsan DS
Indian J Cancer; 2010; 47(3):347-8. PubMed ID: 20587918
[No Abstract] [Full Text] [Related]
4. Plasmacytoma of the testis in a patient with previous multiple myeloma: is the testis a sanctuary site?
Rosenberg S; Shapur N; Gofrit O; Or R
J Clin Oncol; 2010 Sep; 28(27):e456-8. PubMed ID: 20679613
[No Abstract] [Full Text] [Related]
5. Testicular plasmacytoma in a patient with relapsed multiple myeloma.
Pilalas D; Savopoulos C; Vakalopoulos I; Miliaras D; Lefkopoulos A; Kaiafa GD
Int J Hematol; 2020 Aug; 112(2):131-133. PubMed ID: 32514930
[No Abstract] [Full Text] [Related]
6. Plasmacytoid transitional cell carcinoma. Report of a case with initial presentation mimicking multiple myeloma.
Sahin AA; Myhre M; Ro JY; Sneige N; Dekmezian RH; Ayala AG
Acta Cytol; 1991; 35(3):277-80. PubMed ID: 1710402
[TBL] [Abstract][Full Text] [Related]
7. [Plasmacytoma of the ENT region. Diagnosis and therapy].
Waldfahrer F; Heinritz H; Kraus T; Iro H
HNO; 1995 Feb; 43(2):111-29. PubMed ID: 7713763
[No Abstract] [Full Text] [Related]
8. Extramedullary Manifestation of Multiple Myeloma in the Oral Cavity.
de Assis Pereira Hansen C; Filho JS; de Mattos Nascimento M; Alves FA; Neotti T; D Almeida Costa F
Arch Iran Med; 2018 Dec; 21(12):611-612. PubMed ID: 30634861
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Bladder Plasmacytoma Diagnosed during Treatment of Multiple Myeloma].
Yamaguchi R; Shimizu Y; Nakayasu R; Utsunomiya N; Ishihara M; Hashimoto K; Kanamaru S
Hinyokika Kiyo; 2022 May; 68(5):149-153. PubMed ID: 35748233
[TBL] [Abstract][Full Text] [Related]
10. [Extramedullary plasmacytoma].
Sucker C; Stockschläder M
Dtsch Med Wochenschr; 2002 Jan; 127(4):153-5. PubMed ID: 11807659
[No Abstract] [Full Text] [Related]
11. Multiple myeloma.
Kyle RA; Rajkumar SV
N Engl J Med; 2004 Oct; 351(18):1860-73. PubMed ID: 15509819
[No Abstract] [Full Text] [Related]
12. Frequency, distribution and clinical management of incidental findings and extramedullary plasmacytomas in whole body diffusion weighted magnetic resonance imaging in patients with multiple myeloma.
Wale A; Pawlyn C; Kaiser M; Messiou C
Haematologica; 2016 Apr; 101(4):e142-4. PubMed ID: 26819048
[No Abstract] [Full Text] [Related]
13. Advances in the diagnosis and management of myeloma.
Greipp PR
Semin Hematol; 1992 Jul; 29(3 Suppl 2):24-45. PubMed ID: 1509293
[No Abstract] [Full Text] [Related]
14. Extramedullary plasmacytoma of skin, bowel and bladder.
Gesme D; Boatman D; Weinman G; Tewfik H
Iowa Med; 1994 Aug; 84(8):354-5. PubMed ID: 7960638
[No Abstract] [Full Text] [Related]
15. NCCN: Multiple myeloma.
Traynor AE; Noga SJ;
Cancer Control; 2001; 8(6 Suppl 2):78-87. PubMed ID: 11760563
[TBL] [Abstract][Full Text] [Related]
16. Extramedullary plasmacytoma associated with multiple myeloma.
Diwan AG; Gholap NN; Taneja SR
J Assoc Physicians India; 2003 Feb; 51():236-7. PubMed ID: 12725283
[No Abstract] [Full Text] [Related]
17. Erythematous Papule on the Glans Penis.
Munera-Campos M; Plana-Pla A; Quer A
JAMA Dermatol; 2019 Feb; 155(2):247-248. PubMed ID: 30484827
[No Abstract] [Full Text] [Related]
18. Lenalidomide is active for extramedullary disease in refractory multiple myeloma.
Nakazato T; Mihara A; Ito C; Sanada Y; Aisa Y
Ann Hematol; 2012 Mar; 91(3):473-4. PubMed ID: 21647581
[No Abstract] [Full Text] [Related]
19. Cranial nerve palsy in multiple myeloma and solitary plasmacytoma.
Kashyap R; Kumar R; Kumar S
Asia Pac J Clin Oncol; 2010 Dec; 6(4):251-5. PubMed ID: 21114773
[TBL] [Abstract][Full Text] [Related]
20. Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma.
Terpos E; Rezvani K; Basu S; Milne AE; Rose PE; Scott GL; Rahemtulla A; Samson D; Apperley JF
Eur J Haematol; 2005 Nov; 75(5):376-83. PubMed ID: 16191086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
